Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers

類似資料

• Effect of Low-Dose Ritonavir on the Pharmacokinetics of the CXCR4 Antagonist AMD070 in Healthy Volunteers
  著者:: Cao, Ying Jun, 等
  出版事項: (2008)
• The CXCR4 Antagonist AMD3100 Efficiently Inhibits Cell-Surface-Expressed Human Immunodeficiency Virus Type 1 Envelope-Induced Apoptosis
  著者:: Blanco, Julià, 等
  出版事項: (2000)
• AMD3100, a CxCR4 Antagonist, Attenuates Allergic Lung Inflammation and Airway Hyperreactivity
  著者:: Lukacs, Nicholas W., 等
  出版事項: (2002)
• Suppression of Dualtropic Human Immunodeficiency Virus Type 1 by the CXCR4 Antagonist AMD3100 Is Associated with Efficiency of CXCR4 Use and Baseline Virus Composition
  著者:: Fransen, Signe, 等
  出版事項: (2008)
• Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
  著者:: Nervi, Bruno, 等
  出版事項: (2009)